strontium has been researched along with zoledronic acid in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taguchi, T | 1 |
| Kamoto, T | 1 |
| Autio, KA; Morris, MJ; Scher, HI | 1 |
| Tao, H; Wang, M; Wang, Y; Wang, Z; Yu, X | 1 |
| Bigi, A; Boanini, E; Della Bella, E; Fini, M; Gazzano, M; Torricelli, P | 1 |
| Axente, E; Bigi, A; Boanini, E; Fini, M; Mihailescu, IN; Sima, F; Torricelli, P | 1 |
| Hu, J; Li, Y; Shui, X; Zhang, L | 1 |
| Andronis, L; Barton, D; Beesley, S; Billingham, LJ; Birtle, A; Brown, J; Chakraborti, P; Collins, S; Daunton, A; Goranitis, I; Hussain, S; James, ND; McLaren, D; O'Sullivan, J; Parker, C; Pirrie, SJ; Pope, AM; Porfiri, E; Russell, M; Staffurth, J; Stanley, A; Wylie, J | 1 |
| Andronis, L; Barton, D; Beesley, S; Billingham, LJ; Birtle, A; Brown, JE; Chakraborti, P; Collins, S; Daunton, A; Goranitis, I; Hussain, SA; James, ND; McLaren, D; O'Sullivan, JM; Parker, C; Pirrie, S; Pope, A; Porfiri, E; Russell, JM; Staffurth, J; Stanley, A; Wylie, J | 1 |
| Karasik, D; Khajuria, DK; Razdan, R; Trebbin, M; Vasireddi, R | 1 |
| Li, M; Lu, Y; Mao, C; Wan, P; Wang, W; Yang, K; Zhang, Y; Zhu, Y | 1 |
| Han, Y; Li, M; Wan, P; Wang, W; Yang, K; Zhang, Y | 1 |
3 review(s) available for strontium and zoledronic acid
| Article | Year |
|---|---|
[Encounter of cancer cells with bone. Treatment of bone metastases from breast cancer].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Denosumab; Diphosphonates; Female; Humans; Imidazoles; Molecular Targeted Therapy; Osteoclasts; Pamidronate; RANK Ligand; Strontium; Zoledronic Acid | 2011 |
[Encounter of cancer cells with bone. Management of bone metastasis arising from prostate cancer].
Topics: Antibodies, Monoclonal; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Evidence-Based Medicine; Humans; Imidazoles; Male; Molecular Targeted Therapy; NF-kappa B; Prostatic Neoplasms; Radioisotopes; Radium; Receptor Activator of Nuclear Factor-kappa B; Strontium; Zoledronic Acid | 2011 |
Therapeutic strategies for bone metastases and their clinical sequelae in prostate cancer.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bone Neoplasms; Denosumab; Diphosphonates; Fractures, Bone; Humans; Imidazoles; Male; Organometallic Compounds; Organophosphorus Compounds; Pain Management; Prostatic Neoplasms; Strontium; Zoledronic Acid | 2012 |
3 trial(s) available for strontium and zoledronic acid
| Article | Year |
|---|---|
Clinical significance of zoledronic acid and strontium-89 in patients with asymptomatic bone metastases from non-small-cell lung cancer.
Topics: Adult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Humans; Hypercalcemia; Imidazoles; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Paraneoplastic Syndromes; Spinal Cord Compression; Strontium; Zoledronic Acid | 2013 |
Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both: The TRAPEZE Randomized Clinical Trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Diphosphonates; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Humans; Imidazoles; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Prostatic Neoplasms; Strontium; Taxoids; Zoledronic Acid | 2016 |
Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747).
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Cost-Benefit Analysis; Diphosphonates; Disease-Free Survival; Humans; Imidazoles; Male; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radiopharmaceuticals; Strontium; United Kingdom; Zoledronic Acid | 2017 |
6 other study(ies) available for strontium and zoledronic acid
| Article | Year |
|---|---|
Combined effect of strontium and zoledronate on hydroxyapatite structure and bone cell responses.
Topics: Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coculture Techniques; Diphosphonates; Durapatite; Humans; Imidazoles; Nanoparticles; Osteoblasts; Osteocytes; Strontium; Zoledronic Acid | 2014 |
Strontium and zoledronate hydroxyapatites graded composite coatings for bone prostheses.
Topics: Bone Substitutes; Cell Line; Cell Survival; Coated Materials, Biocompatible; Coculture Techniques; Diphosphonates; Humans; Hydroxyapatites; Imidazoles; Osteoblasts; Osteoclasts; Prostheses and Implants; Strontium; Zoledronic Acid | 2015 |
Cancellous bone healing around strontium-doped hydroxyapatite in osteoporotic rats previously treated with zoledronic acid.
Topics: Animals; Cancellous Bone; Diphosphonates; Durapatite; Female; Femoral Fractures; Fracture Healing; Imidazoles; Osteoporosis; Rats; Rats, Sprague-Dawley; Strontium; Zoledronic Acid | 2016 |
Novel therapeutic intervention for osteoporosis prepared with strontium hydroxyapatite and zoledronic acid: In vitro and pharmacodynamic evaluation.
Topics: Adsorption; Animals; Biomarkers; Biomechanical Phenomena; Bone Remodeling; Cancellous Bone; Diphosphonates; Drug Liberation; Female; Femur; Hydroxyapatites; Imidazoles; Nanoparticles; Osteoporosis; Rats, Wistar; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Strontium; X-Ray Diffraction; X-Ray Microtomography; Zoledronic Acid | 2017 |
Molecular and cellular mechanisms for zoledronic acid-loaded magnesium-strontium alloys to inhibit giant cell tumors of bone.
Topics: Alloys; Apoptosis; Biocompatible Materials; Bone and Bones; Bone Neoplasms; Calcium Phosphates; Cell Movement; Cytoskeleton; Diphosphonates; Giant Cell Tumor of Bone; Humans; Magnesium; Mitochondria; Neoplasm Metastasis; Neoplasms; NF-kappa B; Osteoclasts; Osteolysis; Oxidative Stress; Recurrence; Risk Factors; Signal Transduction; Strontium; Zoledronic Acid | 2018 |
Regulation of osteogenesis and osteoclastogenesis by zoledronic acid loaded on biodegradable magnesium-strontium alloy.
Topics: Alloys; Animals; Calcification, Physiologic; Cell Differentiation; Coated Materials, Biocompatible; Mice; Osteoblasts; Osteoclasts; Osteogenesis; RAW 264.7 Cells; Strontium; Zoledronic Acid | 2019 |